Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates | Zendy

Kevin R. Forward | Zendy; Donald E. Low | Zendy; Michél Laverdière | Zendy; Robert Rennie | Zendy; Andrew E. Simor | Zendy; Patricia A Franks | Zendy; Members of the Canadian Piperacillin Tazobactam Study Group | Zendy

Open Access

Study of the Comparative Activity of Piperacillin/Tazobactam with Currently Available Antibiotics against 8206 Aerobic Isolates

Author(s) -

Kevin R. Forward,

Donald E. Low,

Michél Laverdière,

Robert Rennie,

Andrew E. Simor,

Patricia A Franks,

Members of the Canadian Piperacillin Tazobactam Study Group

Publication year - 1996

Publication title -

canadian journal of infectious diseases and medical microbiology

Language(s) - English

Resource type - Journals

eISSN - 1918-1493

pISSN - 1712-9532

DOI - 10.1155/1997/632673

Subject(s) - piperacillin , microbiology and biotechnology , tazobactam , klebsiella pneumoniae , piperacillin/tazobactam , antibiotics , ticarcillin , cephalosporin , ampicillin , enterococcus , medicine , biology , clavulanic acid , amoxicillin , antibiotic resistance , escherichia coli , imipenem , bacteria , pseudomonas aeruginosa , biochemistry , genetics , gene

To compare the activity of piperacillin-tazobactam with piperacillin and other parenterally administered antibiotics against aerobic Gram-negative bacilli and Gram-positive cocci isolated from across Canada, and to determine the prevalence of resistance mediated by extended-spectrum cephalosporinases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research